Evidence reviewed: 8 November 2026. Migraine is a neurological disorder that causes recurrent episodes of headache and associated symptoms, often including nausea, sensitivity to light or sound and sometimes neurological symptoms called aura. Migraine attacks can be disabling, but effective acute and preventive treatments are available. The 2026 American Academy of Neurology (AAN) and American Headache Society (AHS) preventive-treatment guideline includes both traditional medicines and newer calcitonin gene-related peptide (CGRP)-targeted therapies. Understanding personal triggers can help, but avoiding every suspected trigger is neither necessary nor a substitute for evidence-based care [1–3].
What does a migraine attack feel like?
A migraine attack often involves a moderate or severe pulsating or throbbing headache, commonly worse with routine activity and accompanied by light or sound sensitivity or nausea. Pain is frequently one-sided but can be bilateral. Untreated attacks commonly last 4–72 hours in adults; children may have different presentations. Not everyone has every textbook feature, and severe disability can occur without a dramatic headache [2].
Some people notice early symptoms (prodrome) such as yawning, mood changes, neck stiffness, food cravings or fatigue. After the headache improves, a postdrome may leave tiredness and difficulty concentrating. These phases are variable; symptoms do not unfold in a fixed sequence in every person.
Migraine with aura versus migraine without aura
Aura involves reversible neurological symptoms, most commonly expanding zigzag lines, flashing lights, blind spots, pins and needles or transient language difficulty. Typical symptoms develop gradually over several minutes and usually resolve within an hour. Migraine aura often occurs before or during the headache, but can occasionally occur without a subsequent headache [2].
Important safety rule: new, sudden, one-sided weakness, a sudden speech problem, or sudden visual loss must not be assumed to be migraine aura. These can be symptoms of stroke or transient ischemic attack (TIA). Seek emergency assessment for new or unusual neurological symptoms, particularly when onset is abrupt, unlike the person’s established pattern.
Common migraine triggers: individual patterns matter
Some people recognize that attacks cluster around sleep disruption, missed meals, dehydration, stress, menstrual hormonal changes, alcohol or particular sensory environments. However, trigger reports are inconsistent, and early migraine symptoms such as food cravings or neck discomfort can be mistaken for causes of the attack. There is no universal list of foods that every person with migraine must eliminate [2,4].
| Potential factor | Practical approach |
|---|---|
| Irregular sleep or shift work | Aim for a consistent and adequate sleep routine when possible. |
| Skipped meals or dehydration | Maintain regular food and fluid intake appropriate to health and activity. |
| Stress and post-stress changes | Use sustainable stress-management and relaxation strategies. |
| Menstrual cycle | Track timing; discuss targeted acute or preventive approaches when attacks predictably cluster. |
| Alcohol or certain foods | Consider patterns in a diary; avoid only a convincing personal trigger rather than imposing a universal restriction. |
| Medication overuse | Review the number of days acute pain medicines or triptans are used, not just the doses. |
A headache diary can record headache days, severity, disability, associated symptoms, medicines taken and menstrual timing. It is particularly useful for understanding treatment response and avoiding the false assumption that one dietary item explains every episode.
When does a headache need urgent medical assessment?
Seek emergency care for a sudden thunderclap headache reaching peak intensity within a minute; a new headache with weakness, speech changes, confusion or seizures; fever with neck stiffness; a headache after substantial trauma; or sudden severe headache in pregnancy or the postpartum period. Other reasons for urgent evaluation include a new progressive headache associated with cancer or immunosuppression, a new headache in an older adult, or new visual loss. An established migraine history does not rule out another cause [2].
How is migraine diagnosed?
Diagnosis is largely clinical using headache characteristics, associated symptoms, duration and neurological examination, based on the International Classification of Headache Disorders (ICHD-3). A routine brain scan is not needed for every typical migraine with a normal examination; imaging is considered when red flags, atypical features or diagnostic uncertainty are present [2].
Episodic migraine generally means fewer than 15 headache days per month. Chronic migraine requires headache on 15 or more days per month for more than three months, with at least eight migraine-feature days monthly in a person with prior migraine attacks [2]. Chronic migraine should not be assumed from one particularly long attack.
Acute treatment: relieving an individual migraine attack
Acute medicines are generally most effective when taken early in the headache phase before pain becomes severe, using a drug and formulation appropriate to the person’s history and previous response. The International Headache Society acute-treatment guidance, summarized in 2026, recognizes several options [3].
Simple analgesics and NSAIDs
For some mild to moderate attacks, ibuprofen, naproxen, aspirin or acetaminophen/paracetamol may help. Selection depends on age, kidney or liver function, gastrointestinal bleeding risk, pregnancy and other medicines. Aspirin is not appropriate for children and should not be self-administered for a possible stroke or unusual new neurological symptoms. Repeated NSAID exposure can cause gastrointestinal, renal and cardiovascular adverse effects [3].
Triptans
Triptans such as sumatriptan, rizatriptan or eletriptan act mainly at 5-HT1B/1D receptors and can be effective for moderate or severe migraine. A clinician may change the triptan or formulation after inadequate response. For some patients, a triptan combined with an NSAID provides better relief. Triptans are generally contraindicated in people with certain established cardiovascular or cerebrovascular diseases or uncontrolled hypertension and require specific medical assessment [3].
Gepants, ditans and medicines for nausea
Gepants (CGRP receptor antagonists), such as ubrogepant or rimegepant, are acute options in eligible adults, particularly when a triptan is unsuitable or ineffective. Lasmiditan is a 5-HT1F agonist with important sedation and driving restrictions where approved. Antiemetics may help when nausea or vomiting prevents effective oral treatment. Drug availability and approvals vary by country; do not mix prescription migraine medicines without checking interactions [3].
Opioids and barbiturate-containing combinations are not recommended for routine migraine management because of adverse effects, dependence and medication-overuse headache. Emergency treatment of severe prolonged attacks needs clinician assessment rather than repeated unsupervised doses.
Medication-overuse headache: a preventable complication
Frequent use of acute medicines may contribute to medication-overuse headache, especially in people with an underlying migraine disorder. Formal diagnostic criteria include headache on 15 or more days monthly and regular overuse of one or more acute medicines for more than three months, with thresholds depending on drug class. Triptans or combination analgesics used on 10 or more days monthly, or simple analgesics/NSAIDs on 15 or more days monthly, are common diagnostic thresholds [2]. Some guidelines advise even more conservative monthly-use limits to reduce risk [3].
People with increasing headache frequency should review acute medication days and discuss preventive treatment; simply escalating painkillers can make the problem harder to manage.
When should migraine prevention be considered?
The 2026 AAN/AHS guideline recommends offering preventive medicines to people who have at least four migraine days per month, or four or more moderate-to-severe headache days monthly, and to people with substantial migraine-related disability [1]. Prevention is individualized; someone with fewer attacks but major impairment may still benefit. A successful plan often reduces attack frequency, intensity, acute-medication use and functional disruption rather than eliminating every headache.
Updated 2026 preventive medicines
The AAN/AHS guideline identifies therapies supported by high- or moderate-confidence efficacy evidence. Choices depend on episodic versus chronic disease, associated conditions, pregnancy plans, cost, safety and patient preference [1].
| Preventive category | Examples and important considerations |
|---|---|
| Beta-blockers | Propranolol has supportive evidence for episodic migraine; evaluate asthma, heart rate and blood pressure before use. |
| Antiseizure medicines | Topiramate can prevent episodic and chronic migraine; consider cognitive effects, kidney-stone risk and serious pregnancy-related risks. Valproate has major fetal and reproductive safety restrictions and is not a casual first choice. |
| CGRP monoclonal antibodies | Erenumab, fremanezumab, galcanezumab and eptinezumab are effective options for selected adults, subject to access and product precautions. |
| Oral CGRP-targeted medicines | Atogepant is supported for episodic and chronic migraine; rimegepant has a preventive indication in some settings. Consider drug interactions and national authorization. |
| OnabotulinumtoxinA | An established preventive option for chronic migraine, administered by trained professionals; not a general treatment for occasional episodic attacks. |
| Other selected medicines | Amitriptyline, metoprolol and other agents may be appropriate for particular patients but have different evidence strength and adverse-effect profiles. |
The 2026 guideline recognizes CGRP therapies as options with meaningful preventive efficacy rather than automatically requiring every patient to fail several older drugs first, though insurance and local formularies may still impose access restrictions [1]. Drug selection and any tapering after a period of good control should be discussed with a clinician.
Non-drug strategies and the role of lifestyle
Regular meals, adequate hydration, consistent sleep, physical activity and stress management can improve general health and may reduce attack burden. Cognitive behavioral therapy, relaxation training and biofeedback have evidence as adjunctive migraine-management approaches for appropriate patients. Headache diaries can track whether a preventive medicine or behavioral change is helping. Do not advise patients to live in constant avoidance of all bright lights, exercise or social activities if that substantially impairs life [1,4].
Migraine during pregnancy or with other medical conditions
Pregnancy and potential pregnancy change medicine selection substantially. Some effective preventives, particularly valproate and topiramate, have important fetal risks and may be contraindicated or tightly restricted depending on indication and jurisdiction. Some acute medicines also require assessment. People contemplating pregnancy should seek a preconception medication review, rather than stopping therapy without a plan. Triptans and certain preventive agents may be unsuitable in cardiovascular disease; kidney, liver and drug-interaction issues also matter [1,3].
Frequently asked questions
Is migraine always a one-sided headache?
No. Migraine can be bilateral, and associated neurological and sensory symptoms are part of the diagnosis [2].
Can a migraine cause visual zigzags or tingling?
Yes, in migraine with aura; new or abrupt stroke-like symptoms still require emergency assessment.
Should I avoid chocolate, cheese and every ‘migraine trigger’ food?
No. Identify personally consistent patterns; restrictive diets without clear benefit are often unnecessary.
When should prevention start?
Offer prevention at four or more migraine days monthly or substantial disability under the updated AAN/AHS guidance [1].
Do CGRP medicines cure migraine?
No. They can reduce the burden in suitable patients, but regular review and individual treatment planning remain important.
Key takeaways
Confirm migraine clinically, recognize red flags, treat attacks early and monitor medication use. The 2026 AAN/AHS guideline supports effective preventive medicines—including CGRP-targeted therapies—for frequent or disabling migraine. Management should reduce disability without unnecessary restrictions or unsafe self-medication.
References
- Potrebic S, et al. Pharmacologic treatment for migraine prevention in adults: practice guideline recommendations. Headache. 2026;66:2173–2184. doi:10.1111/head.70199. AAN/AHS guideline summary.
- International Headache Society. The International Classification of Headache Disorders, 3rd edition (ICHD-3). Accessed 8 Nov 2026.
- Arnold MJ. Acute migraine treatment: guidelines from the International Headache Society. Am Fam Physician. 2026;113(2):196–198. Clinical summary.
- National Institute for Health and Care Excellence. Headaches in over 12s: diagnosis and management (CG150). Accessed 8 Nov 2026.
Medical disclaimer: This article provides general information and is not a substitute for clinical diagnosis or an individualized prescription. Headache with sudden neurological signs, thunderclap onset or serious systemic symptoms needs immediate medical assessment. Migraine medicines have important contraindications and pregnancy considerations.
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.